Hypha Labs, Inc.
FUNI
$0.0265
$0.00145.58%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.65% | 7.87% | 1,748.87% | 518.45% | 1,009.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.65% | 7.87% | 1,748.87% | 518.45% | 1,009.58% |
| Operating Income | 12.65% | -7.87% | -1,748.87% | -518.45% | -1,009.58% |
| Income Before Tax | 22.97% | -7,922.50% | -850.07% | -184.40% | -376.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.50% | -1,031.92% | -850.07% | -177.38% | -362.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.50% | -372.18% | -983.64% | -278.48% | -340.85% |
| EBIT | 12.65% | -7.87% | -1,748.87% | -518.45% | -1,009.58% |
| EBITDA | 13.33% | -- | -- | -1,556.44% | -14,507.14% |
| EPS Basic | 37.88% | -288.46% | -735.29% | -230.00% | -288.57% |
| Normalized Basic EPS | 29.73% | 29.55% | -560.00% | -125.00% | -236.36% |
| EPS Diluted | 59.00% | -484.62% | -735.29% | -230.00% | -385.71% |
| Normalized Diluted EPS | 29.73% | 29.55% | -560.00% | -125.00% | -236.36% |
| Average Basic Shares Outstanding | 27.12% | 42.35% | 43.08% | 36.09% | 28.17% |
| Average Diluted Shares Outstanding | 27.12% | 42.35% | 43.08% | 36.09% | 28.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |